Targeted screening strategies to detect Trypanosoma cruzi infection in children
- PMID: 18160979
- PMCID: PMC2154390
- DOI: 10.1371/journal.pntd.0000103
Targeted screening strategies to detect Trypanosoma cruzi infection in children
Abstract
Background: Millions of people are infected with Trypanosoma cruzi, the causative agent of Chagas disease in Latin America. Anti-trypanosomal drug therapy can cure infected individuals, but treatment efficacy is highest early in infection. Vector control campaigns disrupt transmission of T. cruzi, but without timely diagnosis, children infected prior to vector control often miss the window of opportunity for effective chemotherapy.
Methods and findings: We performed a serological survey in children 2-18 years old living in a peri-urban community of Arequipa, Peru, and linked the results to entomologic, spatial and census data gathered during a vector control campaign. 23 of 433 (5.3% [95% CI 3.4-7.9]) children were confirmed seropositive for T. cruzi infection by two methods. Spatial analysis revealed that households with infected children were very tightly clustered within looser clusters of households with parasite-infected vectors. Bayesian hierarchical mixed models, which controlled for clustering of infection, showed that a child's risk of being seropositive increased by 20% per year of age and 4% per vector captured within the child's house. Receiver operator characteristic (ROC) plots of best-fit models suggest that more than 83% of infected children could be identified while testing only 22% of eligible children.
Conclusions: We found evidence of spatially-focal vector-borne T. cruzi transmission in peri-urban Arequipa. Ongoing vector control campaigns, in addition to preventing further parasite transmission, facilitate the collection of data essential to identifying children at high risk of T. cruzi infection. Targeted screening strategies could make integration of diagnosis and treatment of children into Chagas disease control programs feasible in lower-resource settings.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Comment in
-
Combining residual insecticide spraying campaigns with targeted detection and specific chemotherapy for Trypanosoma cruzi infection in children.Gürtler RE. Gürtler RE. PLoS Negl Trop Dis. 2007 Dec 26;1(3):e168. doi: 10.1371/journal.pntd.0000168. PLoS Negl Trop Dis. 2007. PMID: 18160985 Free PMC article. No abstract available.
References
-
- Dias JC, Silveira AC, Schofield CJ. The impact of Chagas disease control in Latin America: a review. Mem Inst Oswaldo Cruz. 2002;97:603–612. - PubMed
-
- Kirchhoff LV. American trypanosomiasis (Chagas' disease). Gastroenterol Clin North Am. 1996;25:517–533. - PubMed
-
- WHO Expert Committee. Brasilia, Brazil: World Health Organization; 2000. Control of Chagas Disease. pp. 1–109. WHO technical report series number 905 WHO technical report series number 905.
-
- de Andrade AL, Zicker F, de Oliveira RM, Almeida Silva S, Luquetti A, et al. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet. 1996;348:1407–1413. - PubMed
-
- de Andrade AL, Zicker F, Rassi A, Rassi AG, Oliveira RM, et al. Early electrocardiographic abnormalities in Trypanosoma cruzi-seropositive children. Am J Trop Med Hyg. 1998;59:530–534. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical